Evidence map›Paper›PMID 22236917›Full record

ArticleThe international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease2012

DOT associated with reduced all-cause mortality among tuberculosis patients in Taipei, Taiwan, 2006-2008.

Y-F Yen, T C Rodwell, M-Y Yen, H-C Shih, B-S Hu, L-H Li, Y-H Shie, P Chuang, R S Garfein

Open access · greenAbstract readComparative Study
In one paragraph

Article in The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Y-F YenSection of Infectious Diseases, Taipei City Hospital, Taipei City Government, Taipei, Taiwan.
T C Rodwell
M-Y Yen
H-C Shih
B-S Hu
L-H Li
Y-H Shie
P Chuang
R S Garfein
Taipei Municipal YangMing Hospital · TWUniversity of California, San Diego · USTaipei City Government · TWTaipei City Hospital · TW

Funding

Center for HIV/AIDS Minority Pipeline in Substance Abuse Research (CHAMPS)R25DA025571 · NIDA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI STRATHDEE, STEFFANIE A. · 2008 to 2010
$784k
Binational Transmission of Multidrug-Resistant Tuberculosis, California & MexicoK01AI083784 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI RODWELL, TIMOTHY CHARLES · 2009 to 2012
$487k
NIAID NIH HHS K01 AI083784NIAID NIH HHS K01AI083784NIDA NIH HHS R25 DA025571NIDA NIH HHS R25-DA 025571
6 · The paper itself

Abstract

objectiveTo determine whether patients receiving directly observed treatment (DOT) had lower all-cause mortality than those treated with self-administered treatment (SAT) and to identify factors associated with mortality among tuberculosis (TB) patients.

designAll TB patients in Taipei, Taiwan, diagnosed between 2006 and 2008 were included in a retrospective cohort study.

resultsAmong 3624 TB patients, 45.5% received DOT, which was disproportionately offered to older patients and those with more underlying illness and severe TB disease. After controlling for patients' sociodemographic factors, clinical findings and underlying comorbidities, the odds of death were 40% lower (aOR 0.60, 95%CI 0.5-0.8) among patients treated with DOT than those on SAT. After adjusting for DOT, independent predictors of death included non-Taiwan birth, increasing age, male, unemployment, end-stage renal disease requiring dialysis, malignancy, acid-fast bacilli smear positivity and pleural effusion.

conclusionDOT was associated with lower all-cause mortality after controlling for confounding factors. DOT should be expanded in Taiwan to improve critical treatment outcomes among TB patients.

Indexed as

AgedAntitubercular AgentsCause of DeathDirectly Observed TherapyFemaleFollow-Up StudiesHumansMaleMiddle AgedRetrospective StudiesRisk FactorsSurvival RateTaiwanTreatment OutcomeTuberculosisAntitubercular Agents

Identifiers

PMID22236917
PMCPMC3289585
OpenAlexW2042299425

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.